FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4511511000001107: Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26579101000001115 Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41473901000001114 Razoxane 125mg tablets (Cambridge Laboratories Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Is a Razoxane 125mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Is pack of Razoxane 125mg tablets (Cambridge Laboratories) false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has active ingredient Cytoprotective agent false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has active ingredient Antidote false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has active ingredient Razoxane false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has AMP Razoxane 125mg tablets (Cambridge Laboratories) true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has specific active ingredient Razoxane true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Cambridge Laboratories) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start